Favipiravir-Induced Nephrotoxicity in a Patient with COVID-19: a case
report
- Asmaa Abdelbary,
- Ahmad Alharafsheh,
- Afif Ahmed,
- Abdulqadir Nashwan
Abstract
This report describes a case of 45 years old male patient who tested
positive for COVID-19 presented to the emergency department on March
2021 complaining of fever, cough, runny nose, and shortness of breath.
The patient denied any history of nausea or diarrhea who has eventually
developed favipiravir-induced nephrotoxicity.18 Apr 2021Submitted to Clinical Case Reports 19 Apr 2021Submission Checks Completed
19 Apr 2021Assigned to Editor
25 Apr 2021Reviewer(s) Assigned
31 May 2021Review(s) Completed, Editorial Evaluation Pending
11 Jun 2021Editorial Decision: Revise Minor
14 Jun 20211st Revision Received
14 Jun 2021Submission Checks Completed
14 Jun 2021Assigned to Editor
14 Jun 2021Review(s) Completed, Editorial Evaluation Pending
15 Jun 2021Editorial Decision: Accept
